Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VSIR | Q9H7M9 | 7/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | PDCD1 | Q15116 | 4/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 4/20 | 0.32 |
| ▸ | CLK1 | P49759 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CTSA | P10619 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30153124 | 0.93 | VSIR (0.35) | VSIRKCNH2PDCD1CD274CLK1 | |
| SCHEMBL24818733 | 0.89 | KCNH2 (0.39) | VSIRKCNH2PDCD1CD274CLK1 | |
| SCHEMBL30152743 | 0.89 | KCNH2 (0.39) | VSIRKCNH2PDCD1CD274CLK1 | |
| SCHEMBL24818734 | 0.89 | KCNH2 (0.39) | VSIRKCNH2PDCD1CD274CLK1 | |
| SCHEMBL24821916 | 0.88 | KCNH2 (0.37) | VSIRKCNH2PDCD1CD274CLK1 | |
| SCHEMBL24819922 | 0.88 | KCNH2 (0.37) | VSIRKCNH2PDCD1CD274CLK1 | |
| SCHEMBL24819926 | 0.86 | KCNH2 (0.47) | VSIRKCNH2PDCD1CD274CLK1 | |
| SCHEMBL24819863 | 0.85 | CD274 (0.39) | VSIRKCNH2PDCD1CD274 | |
| SCHEMBL24818952 | 0.85 | VSIR (0.41) | VSIRKCNH2PDCD1CD274 | |
| SCHEMBL30153006 | 0.85 | VSIR (0.41) | VSIRKCNH2PDCD1CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022272248-A1 | CBL-B MODULATORS AND USES THEREOF | NIMBUS CLIO, INC. (US) | 2022-12-29 | — | — | WO | disclosed |